PHILADELPHIA — The investigational drug verekitug improved sinonasal symptoms, reduced nasal polyp size, and reduced the need for nasal polyp surgery in people with chronic rhinosinusitis with nasal ...
SOUTH BEND, IN (WSBT) — The FDA has approved the first ever nasal medication called “Neffy” for severe allergies. It’s a new alternative to the well-known EpiPen. Severe allergic reactions are scary, ...
The Food and Drug Administration on Thursday approved a new nasal spray to treat migraines. The spray will be available in July and is designed to treat migraines in 15 minutes. Pfizer acquired the ...
Medications such as nasal decongestants and cough suppressants may help manage symptoms of upper respiratory infections. Most respiratory infections clear up with self-care at home. A respiratory ...
ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical ...
DUBLIN--(BUSINESS WIRE)--The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Inhalation and ...
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental ...
Onlymyhealth on MSN
Why is Your Nose Always Clogged? Know Here
A persistently blocked nose is more than just an inconvenience. For many people, it becomes a daily struggle that affects sleep, breathing, concentration, and overall quality of life. While occasional ...
One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked. This makes breathing in through your nostrils frustrating—if not ...
You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...
The FDA has supported the Phase 3 design for BPL-003, an intranasal psychedelic-derived therapy for treatment-resistant depression AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results